Ann: MVP Announces $10M Capital Raise, page-17

Yes I wonder about that too. At least I was a little uncertain as to how they costed their result and how much the self administered element came into the mix. I'm just relaying what I read.

The underlying issue here is that success, I think, is linked to the ability of the marketing teams to introduce Penthrox into hospital emergency departments
and short surgical procedures where costs are an urgent issue right now.
There hasn't been any measurable success here and my thoughts are that costs may be a stumbling block.

The thrust of this discussion is whether or not the business model can't be made to work, or it can be made to work but management's just not very good at it.
Because I don't have any connection to the industry, I'm not sure I know the answers, but I think they're the questions.